Black Rose Industries Limited submitted its Q2 FY27 Performance Review and Business Update to BSE Limited on November 16, 2026. The disclosure was signed by Srishti Gour, Company Secretary & Compliance Officer, and Ambarish Daga, Executive Director and Investor Relations Officer.

Financial Performance (Standalone)

The company reported strong financial performance for Q2 FY27 with significant year-on-year improvement across all key metrics:

Quarterly Comparison (₹ crores):

  • Revenue: ₹91.25 (Q2 FY27) vs ₹84.31 (Q2 FY26) - up 8.23%
  • EBITDA: ₹15.67 vs ₹7.54 - up 107.74%
  • PBT: ₹14.29 vs ₹6.09 - up 134.74%
  • PAT: ₹10.49 vs ₹4.43 - up 136.70%

Sequential Comparison (Q2 FY27 vs Q1 FY27):

  • Revenue increased 1.23% from ₹90.14 crore
  • EBITDA increased 1.49% from ₹15.44 crore
  • PBT increased 1.04% from ₹14.14 crore
  • PAT increased 0.78% from ₹10.41 crore

Segment-wise Performance (Standalone)

Q2 FY27 Segment Results (₹ crores):

  • Distribution Division: Sales ₹57.78, EBITDA ₹6.29
  • Manufacturing Division: Sales ₹29.50, EBITDA ₹8.50
  • Unallocated (administrative and CSR expenses): Sales ₹3.96, EBITDA ₹0.89

Q2 FY26 Segment Results (₹ crores):

  • Distribution Division: Sales ₹52.56, EBITDA ₹3.08
  • Manufacturing Division: Sales ₹31.32, EBITDA ₹6.01
  • Unallocated: Sales ₹0.43, EBITDA -₹1.55

Key Financial Indicators

  • Distribution:Manufacturing Revenue Ratio: 1.96:1 (Q2 FY27) vs 1.68:1 (Q2 FY26)
  • Debt:Equity Ratio: 0.000 (Q2 FY27) vs 0.043 (Q2 FY26)
  • Quarterly Interest Coverage Ratio: 73.4 times (Q2 FY27) vs 12.95 times (Q2 FY26)
  • Quarterly Inventory Turnover Ratio: 1.05 times (Q2 FY27) vs 1.02 times (Q2 FY26)
  • Quarterly Return on Equity: 24.1% (Q2 FY27) vs 11.40% (Q2 FY26)
  • Current Ratio: 2.99 (end Q2 FY27) vs 3.09 (end Q2 FY26)
  • Quick Ratio: 1.89 (end Q2 FY27) vs 1.51 (end Q2 FY26)
  • EBITDA Margin: 17.87% (Q2 FY27) vs 8.98% (Q2 FY26)
  • Net Profit Margin: 11.96% (Q2 FY27) vs 5.28% (Q2 FY26)

Business Update - Manufacturing Division

Acrylamide Liquid:

  • Sales volumes remained broadly stable sequentially
  • Volumes moderated compared to Q2 FY26 but higher realizations maintained revenue levels
  • Principal raw material acrylonitrile remained stable through most of quarter, closing at approximately USD 1,560/MT
  • Favourable realizations and improved spreads supported profitability

Acrylamide Solid:

  • Delivered strong performance with volumes more than doubling over previous quarter
  • Company is only global manufacturer of solid acrylamide outside China
  • Benefited from favourable market conditions with elevated logistics costs increasing landed cost of Chinese supplies
  • Strong demand supported higher realizations and improved spreads

N-Methylol Acrylamide:

  • Sales volumes lower compared to preceding quarter due to seasonal weakness and reduced offtake from key customer
  • Company focusing on new customer additions and market reach expansion

Business Update - Distribution Division

  • Delivered healthy performance with revenue improving year-on-year
  • Profitability increased significantly compared to Q2 FY26
  • Revenue and profitability moderated sequentially due to lower acrylonitrile volumes and export sales
  • Demand across key product segments remained stable

Outlook

Manufacturing Division:

  • Expects stable demand conditions across key product segments
  • Higher acrylonitrile prices may pressure spreads
  • Benefits from established market position, diversified customer base, and operational efficiency focus

Distribution Division:

  • Expects improved performance supported by healthy demand across domestic markets and US oil & gas sector
  • Strong principal relationships and stable demand expected to provide favourable operating environment
  • Profitability expected to remain steady with disciplined execution

Projects and Expansions

  • Polyacrylamide (PAM) solid project advanced significantly in piloting phase
  • On track for commercialization in next fiscal year (FY28)
  • Development of downstream products based on acrylamide chemistry progressing as planned
  • Specialty amines project with Koei Chemical Company, Ltd. progressed during quarter
  • Investment decision expected during the year
  • Company to provide further updates as key milestones achieved

Disclaimer

The document contains forward-looking statements subject to risks and uncertainties including availability and cost of raw materials, demand fluctuations, exchange rate changes, government policies, tax structure changes, and economic developments. The company undertakes no obligation to publicly update any forward-looking statements.